Volume 101 Number 4
Published online 11 August 2009 (551 - 742)
---------------------------------------------------------------------
Announcing the NEW British Journal of Cancer impact factor: 4.846*
*2008 Journal Citation Report (Thomson Reuters, 2009)
---------------------------------------------------------------------
COMING SOON - A WEB FOCUS ON HUMAN PAPILLOMAVIRUS
Late summer 2009
The web focus will bring together a selection of key articles
recently published by BJC in this field.
----------------------
MINIREVIEW
----------------------
Role of miRNAs in the progression of malignant melanoma
D W Mueller and A K Bosserhoff
Abstract: http://links.ealert.nature.com/ctt?kn=56&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=57&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
----------------------
CLINICAL STUDIES
----------------------
The impact of young age on cancer-specific and non-cancer-related survival after surgery for colorectal cancer: 10-year follow-up
D C McMillan and C S McArdle
Abstract: http://links.ealert.nature.com/ctt?kn=100&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=108&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Follow-up care for cancer survivors: views of the younger adult
K Absolom, C Eiser, G Michel, S J Walters, B W Hancock, R E Coleman, J A Snowden and D M Greenfield
Abstract: http://links.ealert.nature.com/ctt?kn=107&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=34&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Follow-up care for cancer survivors: the views of clinicians
D M Greenfield, K Absolom, C Eiser, S J Walters, G Michel, B W Hancock, J A Snowden and R E Coleman
Abstract: http://links.ealert.nature.com/ctt?kn=17&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=122&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study
T Wethal, M-B Lund, T Edvardsen, S D Fossa, A H Pripp, H Holte, J Kjekshus and A Fossa
Abstract: http://links.ealert.nature.com/ctt?kn=120&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=14&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage
S J Howell, C Searle, V Goode, T Gardener, K Linton, R A Cowan, M A Harris, P Hopwood, R Swindell, A Norman, J Kennedy, A Howell, A M Wardley and J A Radford
Abstract: http://links.ealert.nature.com/ctt?kn=103&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=83&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer
A Daskalaki, S Agelaki, M Perraki, S Apostolaki, N Xenidis, E Stathopoulos, E Kontopodis, D Hatzidaki, D Mavroudis and V Georgoulias
Abstract: http://links.ealert.nature.com/ctt?kn=43&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=8&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study
Y Park, K Okamura, S Mitsuyama, T Saito, J Koh, S Kyono, K Higaki, M Ogita, T Asaga, H Inaji, H Komichi, N Kohno, K Yamazaki, F Tanaka, T Ito, H Nishikawa, A Osaki, H Koyama and T Suzuki
Abstract: http://links.ealert.nature.com/ctt?kn=50&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=72&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer
E-M Boneberg, D F Legler, M M Hoefer, C Ohlschlegel, H Steininger, L Fuzesi, G M Beer, V Dupont-Lampert, F Otto, H-J Senn and G Furstenberger
Abstract: http://links.ealert.nature.com/ctt?kn=28&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=89&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Two phase II trials of temozolomide with interferon-[alpha]2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme
M D Groves, V K Puduvalli, M R Gilbert, V A Levin, C A Conrad, V H Liu, K Hunter, C Meyers, K R Hess and W K Alfred Yung
Abstract: http://links.ealert.nature.com/ctt?kn=62&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=29&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study
J W Valle, H Wasan, P Johnson, E Jones, L Dixon, R Swindell, S Baka, A Maraveyas, P Corrie, S Falk, S Gollins, F Lofts, L Evans, T Meyer, A Anthoney, T Iveson, M Highley, R Osborne and J Bridgewater
Abstract: http://links.ealert.nature.com/ctt?kn=90&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=104&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
----------------------
TRANSLATIONAL THERAPEUTICS
----------------------
The role of apoptotic cell death in the radiosensitising effect of gemcitabine
B Pauwels, J B Vermorken, A Wouters, J Ides, S Van Laere, H A J Lambrechts, G G O Pattyn, K Vermeulen, P Meijnders and F Lardon
Abstract: http://links.ealert.nature.com/ctt?kn=33&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=92&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by AP-2[alpha] overexpression
N Jonckheere, V Fauquette, L Stechly, N Saint-Laurent, S Aubert, C Susini, G Huet, N Porchet, I Van Seuningen and P Pigny
Abstract: http://links.ealert.nature.com/ctt?kn=46&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=53&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours
J K J Ahlskog, C Schliemann, J Marlind, U Qureshi, A Ammar, R B Pedley and D Neri
Abstract: http://links.ealert.nature.com/ctt?kn=88&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=3&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Peripheral neural cell sensitivity to mTHPC-mediated photodynamic therapy in a 3D in vitro model
K E Wright, E Liniker, M Loizidou, C Moore, A J MacRobert and J B Phillips
Abstract: http://links.ealert.nature.com/ctt?kn=24&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=4&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
----------------------
MOLECULAR DIAGNOSTICS
----------------------
Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease
J E Bluff, S R Menakuru, S S Cross, S E Higham, S P Balasubramanian, N J Brown, M W Reed and C A Staton
Abstract: http://links.ealert.nature.com/ctt?kn=110&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=27&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype
G Grelier, N Voirin, A-S Ay, D G Cox, S Chabaud, I Treilleux, S Leon-Goddard, R Rimokh, I Mikaelian, C Venoux, A Puisieux, C Lasset and C Moyret-Lalle
Abstract: http://links.ealert.nature.com/ctt?kn=40&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=114&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Oncolytic activity of Sindbis virus in human oral squamous carcinoma cells
K Saito, K Uzawa, A Kasamatsu, K Shinozuka, K Sakuma, M Yamatoji, M Shiiba, Y Shino, H Shirasawa and H Tanzawa
Abstract: http://links.ealert.nature.com/ctt?kn=41&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=13&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Identification of retinoic acid-regulated nuclear matrix-associated protein as a novel regulator of gastric cancer
J Li, E K O Ng, Y P Ng, C Y P Wong, J Yu, H Jin, V Y Y Cheng, M Y Y Go, P K F Cheung, M P A Ebert, J Tong, K F To, F K L Chan, J J Y Sung, N Y Ip and W K Leung
Abstract: http://links.ealert.nature.com/ctt?kn=18&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=73&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer
E K O Ng, W P Tsang, S S M Ng, H C Jin, J Yu, J J Li, C Rocken, M P A Ebert, T T Kwok and J J Y Sung
Abstract: http://links.ealert.nature.com/ctt?kn=119&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=124&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
----------------------
GENETICS AND GENOMICS
----------------------
MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression
B Diosdado, M A van de Wiel, J S Terhaar Sive Droste, S Mongera, C Postma, W J H J Meijerink, B Carvalho and G A Meijer
Abstract: http://links.ealert.nature.com/ctt?kn=25&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=111&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
F Loupakis, A Ruzzo, C Cremolini, B Vincenzi, L Salvatore, D Santini, G Masi, I Stasi, E Canestrari, E Rulli, I Floriani, K Bencardino, N Galluccio, V Catalano, G Tonini, M Magnani, G Fontanini, F Basolo, A Falcone and F Graziano
Abstract: http://links.ealert.nature.com/ctt?kn=64&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=38&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours
K Jacob, S Albrecht, C Sollier, D Faury, E Sader, A Montpetit, D Serre, P Hauser, M Garami, L Bognar, Z Hanzely, J L Montes, J Atkinson, J-P Farmer, E Bouffet, C Hawkins, U Tabori and N Jabado
Abstract: http://links.ealert.nature.com/ctt?kn=35&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=60&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
----------------------
LETTER TO THE EDITOR
----------------------
Malignant pericardial effusion: sclerotherapy or local chemotherapy[quest]
C Lestuzzi, C Lafaras, A Bearz, R Gralec, E Viel, A Buonadonna and T Bischiniotis
http://links.ealert.nature.com/ctt?kn=16&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
----------------------
REPLY TO LETTER TO THE EDITOR
----------------------
Reply to /`Malignant pericardial effusion: sclerotherapy or local chemotherapy[quest]/'
H Kunitoh, T Tamura and N Saijo
http://links.ealert.nature.com/ctt?kn=77&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
Reply to /`Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis/'
H-A Hou, L-I Lin, C-Y Chen and H-F Tien
http://links.ealert.nature.com/ctt?kn=37&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
----------------------
BOOK REVIEW
----------------------
The WHO's who of haematopoietic malignancies
S H Oram and B Gottgens
http://links.ealert.nature.com/ctt?kn=63&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
----------------------
CORRIGENDUM
----------------------
Hypoxia-inducible factor-1[alpha] and -2[alpha] are expressed in most rectal cancers but only hypoxia-inducible factor-1[alpha] is associated with prognosis
S Rasheed, A L Harris, P P Tekkis, H Turley, A Silver, P J McDonald, I C Talbot, R Glynne-Jones, J M A Northover and T Guenther
http://links.ealert.nature.com/ctt?kn=19&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
---------------------------------------------------------------------
Ensure your access to British Journal of Cancer
If you are unable to access the articles in this Table of Contents e-alert,
your library may not subscribe to this journal. Our online recommendation
form is a simple way to make your librarian aware that this journal is
valuable to your research.
Recommend now at
http://links.ealert.nature.com/ctt?kn=55&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
=====================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=26&m=33851603&r=MTc2MDAwMTgxNgS2&b=2&j=NTY1OTIzNDkS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
© Copyright 2009 Nature Publishing Group
=====================================================================
